findmyKOL

Jennifer Choi, MD

Enriched profile

Professor of Dermatology; Chief of Oncodermatology and Chief of Medical Dermatology, Department of Dermatology · Northwestern University Feinberg School of Medicine

ORCIDNPI
Region🇺🇸 Chicago, IL · Midwest · United StatesSpecialtyDermatologyFocusAcne / Hidradenitis
Active KOLLatest publication2026Online presenceverified 2026Payments2021–2024NIH fundingNone on fileWhy? →

Jennifer Choi is Professor of Dermatology; Chief of Oncodermatology and Chief of Medical Dermatology, Department of Dermatology at Northwestern University Feinberg School of Medicine. OpenAlex indexes 141 publications with 2,467 citations (h-index 24); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Jennifer N. Choi, MD, is Professor of Dermatology at Northwestern University Feinberg School of Medicine. The public record shows 141 publications with 2,467 citations (h-index 24), centered on Acne / Hidradenitis. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 7 companies.

  • Most recent indexed publication: 2026 · Journal of cancer education
  • Top research focus: Acne / Hidradenitis
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 7 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Alopecia1 trialAcne / Hidradenitis1 trialAcne Vulgaris1 trialExanthema1 trial

Research focus

OpenAlex concept fingerprint
Acne / Hidradenitis

Drugs & molecules

across trials, industry payments and publications
Tremfyageneric · GuselkumabClinical trialsIndustry payments2PublicationsEbglyssgeneric · LebrikizumabClinical trialsIndustry payments1PublicationsRinvoqgeneric · UpadacitinibClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Northwestern UniversityClinical trials4Industry paymentsJanssen Biotech, Inc.Clinical trialsIndustry payments2Teva Pharmaceuticals USA, Inc.Clinical trialsIndustry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
141publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

2,467citations

Total citations across indexed works.

24h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials
7companies · 2021–2024

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

7 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    25.8%
    Azole Antifungal17.5%
    Ketoconazole100%
    Part D101 patients
    Lincosamide Antibacterial4.3%
    Clindamycin Phosphate100%
    Part D21 patients
  • Dermatology

    25.1%
    Corticosteroid20%
    Triamcinolone Acetonide60%Triamcinolone acetonide40%
    Part D + Part B93 patients
    Antivirals2.1%
    Imiquimod100%
    Part D13 patients
  • Sensory organs

    18.3%
    Corticosteroid15.6%
    Clobetasol Propionate70%Hydrocortisone22%Desonide9%
    Part D66 patients
    Aminoglycoside Antibacterial1.6%
    Gentamicin Sulfate100%
    Part D14 patients
5 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/jennifer-choi-md-20e955d4

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/Jennifer-Choi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • X / Twitter

    x.com/MDJenniferChoi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com

Mentions by others

where others cite or feature them
  • Other

    cancerwellness.com/a-family-affair-chois

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancerwellness.com
  • Other

    prnewswire.com/news-releases/dr-jennifer-nam-choi-appointed-chief-of-oncodermatology-for-northwestern-medicine-300181934.html

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com
  • X / Twitter

    X/Twitter: @MDJenniferChoi ("Jennifer Choi, MD, FAAD")

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Residency

    Dermatology, Yale-New Haven Medical Center (2007), served as Chief Resident

    2007
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nm.org
  • Internship

    Internal Medicine, Brigham and Women's Hospital / Harvard Medical School

    2004
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nm.org
  • MD

    Yale University School of Medicine

    2003
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nm.org
  • Board Certified

    American Board of Dermatology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nm.org
  • BA

    Harvard University

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →viecure.com
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com

Editorial & leadership roles

journal and society appointments
  • Chief

    Division of Oncodermatology, Department of Dermatology, Northwestern University Feinberg School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu
  • Chief of Medical Dermatology

    Department of Dermatology, Northwestern University Feinberg School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu
  • Director

    Inpatient Dermatology Consult Service and comprehensive skin-cancer surveillance program for high-risk/cancer-survivor patients, Robert H. Lurie Comprehensive Cancer Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.northwestern.edu

Secondary affiliations

appointments beyond the home institution
1 more affiliation behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.